112634 ⎘
Measuring or testing processes involving enzymes, nucleic acids or microorganisms ; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage; Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
CIRCULAR RNA DERIVED FROM RNA VIRUSES AND RELATED COMPOSITIONS AND METHODS
#2Reagents and Methods for Detecting HCV
#3Pathogen Detection From Urine Analyte in All Gender Patients
#4SWITCHABLE NUCLEIC ACID-SCAFFOLDED CATALYTIC SYSTEMS AND METHOD OF USE
#5COMPOSITIONS AND METHODS FOR DETECTING HEV NUCLEIC ACID
#6METHODS OF CAPTURING, SEPARATING, AND/OR ENRICHING LOW ABUNDANT TARGET BIOMOLECULES
#7RAA PRIMERS AND KITS FOR DETECTION OF HEPATITIS C VIRUS
#8METHOS FOR RAPID DETECTION AND IDENTIFICATION OF VIRAL NUCLEIC ACIDS
#9METHOD FOR EVALUATION OF VIABILITY OF VIRUSES WITH LYMPHOTROPISM PROPERTIES
#10EXOSOME-MEDIATED DIAGNOSIS OF HEPATITIS VIRUS INFECTIONS AND DISEASES
#11EXOSOME-MEDIATED DIAGNOSIS OF HEPATITIS VIRUS INFECTIONS AND DISEASES
#12METHODS AND COMPOSITIONS FOR DETECTING TRANSFUSION-TRANSMITTED PATHOGENS
#13DETECTION OF PATHOGENS IN WASTEWATER
#14HCV DETECTION
#15RAPID DIAGNOSTIC SYSTEM USING TARGETED ANTISENSE OLIGONUCLEOTIDE CAPPED PLASMONIC NANOPARTICLES
#16KITS FOR DETECTING HEV NUCLEIC ACID
#17Reagents and methods for detecting HCV
#18Method for evaluation of viability of viruses with lymphotropism properties
#19Fluorescent dyes and methods of use thereof
#20Compositions and methods for detecting HEV nucleic acid
#21A NOVEL INTERFERON-(lambda)4 (IFNL-4) PROTEIN, RELATED NUCLEIC ACID MOLECULES, AND USES THEREOF
#22SYSTEMS and METHODS for DETECTING INFECTIOUS DISEASES
#23Method for evaluation of viability of viruses with lymphotropism properties
#24Methods for diagnosing infectious diseases using adsorption media
#25Methods for real-time multiplex isothermal detection and identification of bacterial, viral, and protozoan nucleic acids
#26Exosome-mediated diagnosis of human immunodeficiency virus infection
#27SYSTEMS and METHODS for DETECTING INFECTIOUS DISEASES
#28Modified oligonucleotides comprising thiol functions and use thereof for detecting nucleic acids
#29Enhanced nucleic acid identification and detection
#30Exosome-mediated diagnosis of hepatitis virus infections and diseases
#31METHODS AND DEVICES FOR DETECTING HEPATITIS C VIRUS
#32Assay for detecting hepatitis C virus (HCV)
#33Compositions and methods for amplifying and characterizing HCV nucleic acid
#34OPTIMIZED REAL-TIME NUCLEIC ACID DETECTION PROCESSES
#35Fluorescent dyes and methods of use thereof
#36COVERED SEQUENCE CONVERSION DNA AND DETECTION METHODS
#37Compositions and methods for detecting HEV nucleic acid
#38Capture probes immobilizable via L-nucleotide tail
#39Method for evaluation of viability of viruses with lymphotropism properties
#40DIAGNOSTIC METHODS AND COMPOSITIONS
#41Detection method for mutation in 93rd amino acid of hepatitis C virus NS5A protein, and detection kit for mutation in 93rd amino acid of hepatitis C virus NS54 protein
#42Method for predicting treatment efficacy of peginterferon plus ribavirin treatment in a subject suffering from hepatitis C
#43METHODS AND DEVICES FOR DETECTING HEPATITIS C VIRUS
#44Devices comprising bacteriophage PHI6 internal control compositions
#45METHOD FOR TEMPLATE-DEPENDENT MULTIPLE DISPLACEMENT AMPLIFICATION
#46Primers, probes and methods for sensitive, specific detection and monitoring of HIV-1 and HCV
#47Helper oligonucleotide for improved efficiency of amplification and detection/quantitation of nucleic acids
#48Employing human adipose-derived stem cells to propagate serum-derived hepatitis C virus and use thereof
#49Compositions and methods for detection of hepatitis C virus genotype 3
#50USE OF RNASE H FOR THE SELECTIVE AMPLIFICATION OF VIRAL DNA
#51Anti-hepatitis C antibodies and antigen binding fragments thereof
#52HEV Assay
#53Interferon-λ4 (IFNL-4) protein, related nucleic acid molecules, and uses thereof
#54Combo-Hepatitis Antigen Assays and Kits for Detection of Active Hepatitis Virus Infections
#55Animal models, cell lines and methods for screening hepatitis C virus vaccines
#56Exosome-mediated diagnosis of hepatitis virus infections and diseases
#57Systems and methods for detecting infectious diseases
#58Enhanced nucleic acid identification and detection
#59Reagents and methods for detecting HCV
#60Dual probe assay for the detection of HCV
#61Method for reduction or elimination of false-negative enzyme immunoassay and polymerase chain reaction testing results
#62Methods for diagnosing infectious diseases using adsorption media
#63Multivolume devices, kits and related methods for quantification and detection of nucleic acids and other analytes
#64METHODS FOR RAPID DETECTION AND IDENTIFICATION OF VIRAL NUCLEIC ACIDS
#65Method for generating high-titer hepatitis E virus stocks and titration assay for hepatitis E virus
#66Methods for purification of a virus produced in vitro and clearance assay for the virus
#67UNIVERSAL CONTROLS FOR SEQUENCING ASSAYS
#68Exosome-mediated diagnosis of hepatitis virus infections and diseases
#69Method for the detection in biological materials of viruses with lymphotropism properties in low concentrations
#70Fluorescent dyes and methods of use thereof
#71HCV GENOTYPING ALGORITHM
#72Optimized real time nucleic acid detection processes
#73Use of Let-7g to down regulate NS5B gene, core protein and viral load of hepatitis C virus
#74Detection of hepatitis delta virus (HDV) for the diagnosis and treatment of Sjögren's syndrome and lymphoma
#75METHODS FOR DETERMINING VIRAL SENSITIVITY TO VIRAL INHIBITORS
#76Diagnostic methods and compositions
#77Primers and methods for detecting human hepatitis C virus (HCV) variants in an isolated sample
#78High-titer HCV full-length genotype 2B infectious cell culture systems and applications thereof
#79Compositions and methods for detecting HEV nucleic acid
#80METHOD FOR DETERMINING DRUG RESISTANCE MUTATIONS IN ANY OF THE NON-STRUCTURAL PROTEIN REGIONS NS3 TO NS5B OF HEPATITIS C VIRUS (HCV) FOR GENOTYPES 1 TO 6
#812′-branched nucleosides and flaviviridae mutation
#82Quantitative multiplexed identification of nucleic acid targets
#83Methods for removing viral contaminants from pancreatic extracts
#84Methods for preparation of nucleic acid-containing samples using clay minerals and alkaline solutions
#85Infectious hepatitis E virus genotype 3 recombinants
#86Methods for diagnosing infectious diseases using adsorption media
#87Systems and methods for detecting infectious diseases
#88Compositions and methods for detecting HEV nucleic acid
#89Interference Control Panel for Evaluation of Analytical Assays for Samples Derived from Blood
#90MODIFIED OLIGONUCLEOTIDES COMPRISING THIOL FUNCTIONS AND USE THEREOF FOR DETECTING NUCLEIC ACIDS
#91MULTIVOLUME DEVICES, KITS AND RELATED METHODS FOR QUANTIFICATION AND DETECTION OF NUCLEIC ACIDS AND OTHER ANALYTES
#92Method for detecting a minority genotype
#93METHOD FOR REPLICATING HCV IN VITRO
#94Covered sequence conversion DNA and detection methods
#95Compositions and methods for amplifying and characterizing HCV nucleic acid
#96HCV full-length infectious cell culture systems and applications thereof
#97Method for evaluation of viability of viruses with lymphotropism properties
#98Infectious hepatitis C viruses of genotype 3A and 4A and uses thereof
#99Molecular detection assay using direct treatment with a bisulphite reagent
#100Interferon-λ4 (IFNL4) protein, related nucleic acid molecules, and uses thereof
#101CHEMILUMINESCENT NANOPARTICLES AND USES THEREOF
#102Interference Control Panel for Evaluation of Analytical Assays For Samples Derived from Blood
#103Nucleic acid construct comprising nucleic acid derived from genome of hepatitis C virus of genotype 1B, hepatitis C virus genome-replicating cells transfected with the same, and method for producing infectious hepatitis C virus particles
#1042'-BRANCHED NUCLEOSIDES AND FLAVIVIRIDAE MUTATION
#105METHODS FOR DETERMINING VIRAL SENSITIVITY TO VIRAL INHIBITORS
#106GENETIC MARKER FOR PREDICTING PROGNOSIS IN PATIENTS INFECTED WITH HEPATITIS C VIRUS
#107METHOD FOR IDENTIFYING MODULATORS OF HCV TRANSLATION OR REPLICATION INVOLVING THE NS5B POLYPEPTIDE AND A PSEUDOKNOT
#108METHODS FOR AMPLIFYING HEPATITIS C VIRUS NUCLEIC ACIDS
#109NEAR FULL-GENOME ASSAY OF HCV DRUG RESISTANCE
#110POLYNUCLEOTIDE DERIVED FROM NOVEL HEPATITIS C VIRUS STRAIN AND USE THEREOF
#111Control nucleic acids for multiple parameters
#112POLYMORPHISMS ASSOCIATED WITH NON-RESPONSE TO A HEPATITIS C TREATMENT OR SUSCEPTIBILITY TO NON-SPONTANEOUS HEPATITIS C CLEARANCE
#113Dual probe assay for the detection of heterogeneous amplicon populations
#114Reagents and methods for detecting HCV
#115HCV genotype 6 replicons
#116Dual probe assay for the detection of HCV
#117Method for preventing high molecular weight products during amplification
#118Fluorescence energy transfer by competitive hybridization
#119ANALYSIS OF HCV GENOTYPES
#120Detection of Mutations in a Gene Associated with Resistance to Viral Infection, OAS1
#121IDENTIFICATION OF TRANSMITTED HEPATITIS C VIRUS (HCV) GENOMES BY SINGLE GENOME AMPLIFICATION
#122Detection of mutations in a gene associated with resistance to viral infection, OAS1
#123Combination of biomarkers for the prognosis of response or non-response to an anti-HCV treatment
#124Infectious hepatitis E virus genotype 3 recombinants
#125Methods for the Phenotypic Detection of HCV Inhibitor Resistant Subpopulations
#126Rapid High Resolution, High Throughput RNA Structure, RNA-Macromolecular Interaction, and RNA-Small Molecule Interaction Mapping
#127UNIVERSAL MULTI-VARIANT DETECTION SYSTEM
#128HEV assay
#129Capture probes immobilizable via L-nucleotide tail
#130Direct detection of unamplified hepatitis C virus RNA using unmodified gold nanoparticles
#131HEPATITIS-C VIRUS TESTING
#132HCV NS5B PROTEASE MUTANTS
#133Fluorescent dyes
#134TURKEY VIRAL HEPATITIS VIRUS AND USES THEREOF
#135METHOD FOR PREDICTING THE RESPONSE OF A SUBJECT SUFFERING FROM A VIRAL INFECTION OF THE LIVER TO AN ANTIVIRAL THERAPY
#136HCV genotype 3 replicons
#137Self-folding amplification of target nucleic acid
#138METHODS AND COMPOSITIONS FOR IDENTIFYING AND CHARACTERIZING HEPATITIS C
#139DETECTION OF MUTATIONS IN A GENE ASSOCIATED WITH RESISTANCE TO VIRAL INFECTION, OAS1
#140HCV CLADE AND PROTOTYPE SEQUENCES THEREOF
#141GENERALIZED NETWORK THREADING APPROACH FOR PREDICTING A SUBJECT'S RESPONSE TO HEPATITIS C VIRUS THERAPY
#142MARKERS ASSOCIATED WITH RIBAVIRIN-INDUCED ANEMIA
#143Universal Multi-Variant Detection System
#144Detection of mutations in a gene associated with resistance to viral infection, OAS1
#145Predictive Value of IL28B Gene Polymorphism Combined with Pretreatment Serum IP-10 Quantification for Response to Peginterferon and Ribavirin Is Enhanced in Comparison with any of these Biomarkers alone
#146Optimized real time nucleic acid detection processes
#147Methods for identifying a virulent strain of a virus
#148METHOD FOR PREDICTING THERAPEUTIC EFFECT ON CHRONIC HEPATITIS C
#149GENETIC MARKERS ASSOCIATED WITH RESPONSE TO CYCLOPHILIN-BINDING COMPOUNDS
#150Polynucleotide derived from novel hepatitis C virus strain and use thereof
#151Control nucleic acids for multiple parameters
#152Prediction of HCV Viral Kinetics in Interferon-Free Treatment
#153Infectious hepatitis C viruses of genotype 3A and 4A and uses thereof
#154Methods and compositions for nucleic acid detection
#155Quantitative multiplexed identification of nucleic acid targets
#156Methods for amplifying hepatitis C virus nucleic acids
#157Fluorescence energy transfer by competitive hybridization
#158ABBREVIATED HCV THERAPY FOR HCV INFECTED PATIENTS WITH IL28B C/C GENOTYPE
#159PROBE SET FOR IDENTIFICATION OF NUCLEOTIDE MUTATION, AND METHOD FOR IDENTIFICATION OF NUCLEOTIDE MUTATION
#160Single Nucleotide Polymorphisms That Predict HCV Treatment Outcomes
#161ANALYSIS OF HCV GENOTYPES
#162COMPOSITIONS AND METHODS FOR PREDICTING HCV SUSCEPTIBILITY TO ANTIVIRAL AGENTS
#163Interference control panel for evaluation of analytical assays for samples derived from blood
#164Probes and Methods for Hepatitis C Virus Typing Using Multidimensional Probe Analysis
#165KIT FOR DETECTING HEPATITIS C VIRUS AND METHOD OF DETECTING HEPATITIS C VIRUS USING THE SAME
#166Hepatitis-C virus testing
#167HCV replicons containing NS5B from genotype 2B
#168Detection of Mutations in a Gene Associated with Resistance to Viral Infection, OAS1
#169Method for determining drug resistance mutations in any of the non-structural protein regions NS3 to NS5B of hepatitis C virus (HCV) for genotypes 1 to 6
#170METHOD OF DETECTING AND QUANTIFYING HEPATITIS C VIRUS
#171METHODOLOGY FOR ANALYSIS OF SEQUENCE VARIATIONS WITHIN THE HCV NS3/4A GENOMIC REGION
#1722′-branched nucleosides and mutation
#173HCV NS3-NS4 Protease Resistance Mutants
#174NOVEL THERAPEUTIC AGENTS AGAINST HEPATITIS
#175Detection of mutations in a gene associated with resistance to viral infection, OAS1
#176Fluorescence energy transfer by competitive hybridization
#177HCV NS3/4A REPLICON SHUTTLE VECTORS
#178Universal multi-variant detection system
#179Nucleic acid comprising chimeric gene derived from hepatitis C virus
#180Detection of hepatitis C virus RNA
#181Near full-genome assay of HCV drug resistance
#182Screening method for prophylactic and/or therapeutic agent for disease accompanied by hepatitis C
#183COMPOSITIONS FOR USE IN IDENTIFICATION OF STRAINS OF HEPATITIS C VIRUS
#184Methods and Compositions for Managing Resistance of Hepatitis C Virus to Immunosuppressant
#185Hepatitis-C virus testing
#186PRIMERS AND PROBES FOR DETECTING HEPATITIS C VIRUS
#187METHOD OF IDENTIFICATION OF GENOTYPE AND SUBTYPE OF HEPATITIS C VIRUS ON A BIOLOGICAL MICROCHIP
#188METHODS AND COMPOSITIONS FOR IDENTIFYING ANTI-HCV AGENTS
#189Methods and reagents for genotyping HCV
#190HCV GENE
#191Method for detection of HCV at the real time PCR with intercalating dye
#192METHOD OF PREDICTING POTENTIAL SEVERITY OF HEPATITIS E, PROBE SETS, AND PRIMER SETS
#193METHOD FOR PREDICTING THE RESPONSE OF A SUBJECT SUFFERING FROM A VIRAL INFECTION OF THE LIVER TO AN ANTIVIRAL THERAPY
#194Nuclease-resistant RNA aptamer inhibiting replication of hepatitis C virus replicon
#195IN VIVO HCV RESISTANCE TO ANTI-VIRAL INHIBITORS
#196Method for evaluating the response of an individual to a treatment with a type I interferon (IFN)
#197Process for typing of HCV isolates
#198Avian hepatitis E virus, vaccines and methods of protecting against avian hepatitis-splenomegaly syndrome and mammalian hepatitis E
#199HEPATITIS C VIRUS INFECTION BIOMARKERS
#200Light emission modifiers and their uses in nucleic acid detection, amplification and analysis
#201Light emission modifiers and their uses in nucleic acid detection, amplification and analysis
#202Light emission modifiers and their uses in nucleic acid detection, amplification and analysis
#203METHODOLOGY FOR ANALYSIS OF SEQUENCE VARIATIONS WITHIN THE HCV NS5B GENOMIC REGION
#204Amino acids in the HCV core polypeptide domain 3 and correlation with steatosis
#205HCV F PROTEIN AND USES THEREOF
#206HCV GENOTYPING AND PHENOTYPING
#207HCV NS3-NS4 protease resistance mutants
#208Primers for isothermal amplification of hepatitis C virus
#209Detection of mutations in a gene associated with resistance to viral infection
#210NS5A nucleotide sequence variation as a marker for interferon response
#211Interference control panel for evaluation of analytical assays for samples derived from blood
#212Methods for Genotyping HVC
#213Detection of mutations in a gene associated with resistance to viral infection, OAS1
#214DIAGNOSIS METHOD OF HEPATIC STEATOSIS USING BIOCHEMICAL MARKERS
#215Probes and methods for hepatitis C virus typing using single probe analysis
#216Methods and compositions for identifying and characterizing hepatitis C
#217NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION
#218Prognostic chronic hepatitis C biomarkers
#219In vitro model for hepatitis c virion production
#220Novel sequences encoding hepatitis C virus glycoproteins
#221Methods for the production of HCV, assaying HCV entry, and screening drugs and cellular receptors for HCV
#222Hepatitis-C virus type 4, 5 and 6
#223Nucleotide mixture for improved nucleic acid amplification performance
#224METHOD OF DETECTING AND QUANTIFYING HEPATITIS C VIRUS
#225Cell lines permissive for HCV replication
#226Nucleic acid detection in pooled samples
#227METHODS AND REAGENTS FOR GENOTYPING HCV
#228Method for detecting base mutation
#229Compositions and methods for detecting an HCV-1 subtype
#230Methods and compositions for identifying and characterizing hepatitis C
#231Methods for Measuring Therapy Resistance
#232Methods for predicting the efficacy or outcome of hcv therapy
#233Hepatitis-C virus type 4, 5 and 6
#234Detection of mutations in a gene associated with resistance to viral infection, OAS1
#235Probes and methods for hepatitis C virus typing using multidimensional probe analysis
#236Quantitative assay for detection of newly synthesized RNA in a cell-free system and identification of RNA synthesis inhibitors
#237Drug-resistant mutants of hepatitis C virus
#238Hepatitis-C virus testing
#239Detection of mutations in a gene associated with resistance to viral infection, OAS2 and OAS3
#240Compositions and methods for determining susceptibility of hepatitis C virus to anti-viral drugs
#241Ketoamides with cyclic P4's as inhibitors of NS3 serine protease of hepatitis C virus
#242Asymmetric PCR coupled with post-PCR characterization for the identification of nucleic acids
#243Probes and methods for hepatitis C virus typing using single probe analysis
#244Light emission modifiers and their uses in nucleic acid detection, amplification and analysis
#245Method of detecting antibodies to HCV
#246Immunodiagnostic assays using reducing agents
#247Ribonuclease resistant RNA preparation and utilization
#248Methods of treatment and diagnosis of patients with hepatitis c infection
#249Polynucleotide probe and primer derived from hepatitis E virus recovered from japanese, chip including the same, kit including the same, and method of detecting hepatitis E virus genome using the same
#250Polynucleotide probe and primer derived from hepatitis E virus recovered from japanese, chip including the same, kit including the same, and method of detecting hepatitis E virus genome using the same
#251Methods and compositions for identifying anti-HCV agents
#252Diagnosis method of hepatic steatosis using biochemical markers
#253Oligonucleotides and methods for detecting hepatitis C viral nucleic acids
#254ADAR1 antiviral pathway
#255Primers for isothermal amplification of hepatitis C virus
#256Nucleotide mixture for improved nucleic acid amplification performance
#257Primer and probe design for efficient amplification and detection of HCV 3' non-translating region
#258Sequences encoding hepatitis C virus glycoproteins
#259NS5A nucleotide sequence variation as a marker for interferon response
#260Avian hepatitis E virus, vaccines and methods of protecting against avian hepatitis-splenomegaly syndrome and mammalian hepatitis E
#261Ketoamides with cyclic P4'S as inhibitors of NS3 protease of hepatitis C virus
#262Hepatitis-C virus type 4, 5 and 6
#263Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
#264HCV peptide compositions
#265Method of detecting and quantifying hepatitis C virus
#266Hepatitis C virus assay systems
#267Non-B, non-C, non-G hepatitis virus gene, polynucleotide, polypeptide, virus particle, method for isolating virus particle, and method for detecting virus
#268HCV NS3-NS4A protease resistance mutants
#269Method and device for the rapid clinical diagnosis of hepatitis C virus (HCV) infection in biological samples
#270Carrier for gene detection and its use for detecting validity of interferon therapy
#271Oligonucleotides and methods for detecting hepatitis C viral nucleic acids
#272Targets for hepatitis C virus infections
#273Assay
#274HCV clade and prototype sequences thereof
#275Hepatitis-C virus type 4, 5, and 6
#2762′-branched nucleosides and Flaviviridae mutation
#277Methods for real-time multiplex isothermal detection and identification of bacterial, viral, and protozoan nucleic acids
#278Methods for rapid detection and identification of viral nucleic acids